Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)

Conditions: Lupus Erythematosus; Systemic Lupus Erythematosus; SLE (Systemic Lupus); Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Granulomatous Polyangiitis; Microscopic Polyangiitis Interventions: Biological: SC291 Sponsors: Sana Biotechnology Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials